Adare Pharma Solutions Overview
- Status
-
Private
- Employees
-
331

- Latest Deal Type
-
Debt
- Financing Rounds
-
4
- Investments
-
3
Adare Pharma Solutions General Information
Description
Operator of a contract manufacturing organization (CMO) focused on providing advanced pharmaceutical technologies, contract development and commercial manufacturing services to biopharmaceutical companies. The company's technology platforms offer taste masking, controlled release, solubility enhancement and patient-centric dosing solutions that facilitate the commercialization of safe pharmaceutical products, helping clients to develop novel, improved medicines and therapies for the global market.
Contact Information
Website
www.adarepharmasolutions.com
Formerly Known As
Pharmatech
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
BPO/Outsource Services
Primary Office
- Princeton Pike Corporate Center, 1200 Lenox Drive
- Suite 100
- Lawrenceville, NJ 08648
- United States
+1 (609) 000-0000
Adare Pharma Solutions Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Adare Pharma Solutions Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a contract manufacturing organization (CMO) focused on providing advanced pharmaceutical technologies, contr
Pharmaceuticals
Lawrenceville, NJ
331
As of 2022
0000
000000000
Adare Pharma Solutions Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CoreRx | Private Equity-Backed | Clearwater, FL | 000 | 0000 | 000000 - 000 | |
00000000 000000 00 | Venture Capital-Backed | Greensboro, NC | 00 | 000.00 | 000000000000 | 000.00 |
0000000 0000000000 | Corporation | Overland Park, KS | 00 | 000.00 | 000000000 | 000.00 |
Adare Pharma Solutions Patents
Adare Pharma Solutions Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190060287-A1 | Tizanidine formulations | Abandoned | 28-Aug-2017 | 0000000000 | 0 |
US-10441554-B2 | Oral amphetamine composition | Active | 10-Mar-2017 | 0000000000 | 00 |
US-20180256515-A1 | Oral amphetamine composition | Abandoned | 10-Mar-2017 | 0000000000 | 0 |
US-20180311187-A1 | Oral amphetamine composition | Granted | 10-Mar-2017 | 0000000000 | |
US-20190336459-A1 | Oral amphetamine composition | Granted | 10-Mar-2017 | A61K31/137 |
Adare Pharma Solutions Executive Team (22)
Adare Pharma Solutions Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
0000 00000000 | Frazier Healthcare Partners | Board Member | 000 0000 |
0000 00000000 | TPG | Board Member | 000 0000 |
00000 000000 | Self | Executive Chairman | 000 0000 |
Adare Pharma Solutions Signals
Adare Pharma Solutions Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Adare Pharma Solutions Investments (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 0000 | 01-Dec-2021 | 0000000000 | BPO/Outsource Services | 00000 000 | |
00000 0000000 | 30-Apr-2020 | 0000000000 | Drug Delivery | 0000 0000 | |
Viactiv Lifestyle | 04-Jan-2017 | Buyout/LBO | Other Consumer Non-Durables |
Adare Pharma Solutions Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 000000000 | 04-Jan-2017 | 0000000000 | Completed |
|